On November 12, 2020 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, reported members of the executive team will present during upcoming virtual investor conferences (Press release, Kezar Life Sciences, NOV 12, 2020, View Source [SID1234570836]). The details of the presentations are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual London Healthcare Conference
Wednesday, November 18, 2020, 1:10pm EST (Fireside Chat)
Presenters: John Fowler, Chief Executive Officer; Christopher Kirk, PhD, Chief Scientific Officer, and Noreen R. Henig, MD, Chief Medical Officer

2020 Evercore ISI HealthCONx Conference
Thursday, December 3, 2020, 1:00pm EST (Presentation)
Presenter: John Fowler, Chief Executive Officer

The presentations will be webcast live and may be accessed in the "Investors and News" section of the Company’s website at www.kezarlifesciences.com. Kezar Life Sciences will maintain an archived replay of the webcasts on its website for 90 days after the conference.